Follow-On Biologics One Possible Fruit Of FDA-Northeastern Collaboration

A research collaboration agreement between FDA and Northeastern University could help agency officials understand the mechanisms of action of follow-on biologics, thus easing the way for these products once Congress establishes an approval pathway